The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“The p53 protein is a tumor suppressor gene product that can block progression of cells through the cell cycle and/or induce apoptosis (Sionov and Haupt, 1999; Somasundaram and El-Deiry, 2000; Vogelstein et al., 2000).”
BackgroundA novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
What's Up and Down with Histone Deacetylation and Transcription?
Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)80211-1 · Cited by 821
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki, H., Altieri, D. C., Lu, C., Toyoda, M., Tenjo, T., & Tanigawa, N. (1998) · PubMed · Cited by 706
An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7
Shin, S., Sung, B.-J., Cho, Y.-S., Kim, H.-J., Ha, N.-C., Hwang, J.-I., Chung, C.-W., Jung, Y.-K., & Oh, B.-H. (2001) · Biochemistry · doi:10.1021/bi001603q · Cited by 674
Takahashi, Y., Rayman, J. B., & Dynlacht, B. D. (2000) · Genes & Development · doi:10.1101/gad.14.7.804 · Cited by 621
The cellular response to p53: the decision between life and death
Sionov, R. V., & Haupt, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203130 · Cited by 601
Brownell, J. E., & Allis, C. D. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80048-7 · Cited by 534
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A. J., & Shenk, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
Lu, C., Altieri, D. C., & Tanigawa, N. (1998) · PubMed · Cited by 501
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation
Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S., & Amati, B. (2001) · Genes & Development · doi:10.1101/gad.906601 · Cited by 499
Monzó, M., Rosell, R., Felip, E., Astudillo, J., Sánchez, J. J., Maestre, J., Martín, C., Font, A., Barnadas, A., & Abad, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2100 · Cited by 487
Murphy, M., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., & George, D. L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2490 · Cited by 455
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Grossman, D., McNiff, J. M., Li, F., & Altieri, D. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00776.x · Cited by 365
Mechanisms of p53-mediated apoptosis
Bates, S., & Vousden, K. H. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050267 · Cited by 305
Wills, K. N., Maneval, D. C., Menzel, P., Harris, M. P., Sutjipto, S., Vaillancourt, M.-T., Huang, W.-M., Johnson, D. E., Anderson, S. C., Wen, S. F., et al. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.9-1079 · Cited by 233
Self-citationChen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900091 · Cited by 207
Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13345 · Cited by 206
Sabbatini, P., Chiou, S.-K., Rao, L., & White, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1060 · Cited by 191
p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding
Lee, K. C., Crowe, A. J., & Barton, M. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1279 · Cited by 175
Transcriptional analysis of human survivin gene expression
LI, F., & ALTIERI, D. C. (1999) · Biochemical Journal · doi:10.1042/bj3440305 · Cited by 171
Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches
Wang, L., Wu, Q., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P., Greene, J. R., Wang, Y., Pickett, C. B., & Liu, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106570200 · Cited by 166
Self-citationTranscriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 151
Borellini, F., & Glazer, R. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53046-5 · Cited by 147
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15237 · Cited by 144
p53 binds to the TATA-binding protein-TATA complex
Martin, D. W., Muñoz, R. M., Subler, M. A., & Deb, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38619-3 · Cited by 113
Ori, A., Zauberman, A., Doitsh, G., Paran, N., Oren, M., & Shaul, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.544 · Cited by 111
Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation
Eberhardy, S. R., D'Cunha, C. A., & Farnham, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005154200 · Cited by 106
p53-Induced Apoptosis as a Safeguard against Cancer
Asker, C., Wiman, K. G., & Selivanova, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1446 · Cited by 92
p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Bargonetti, J., Chicas, A., White, D., & Prives, C. L. (1997) · PubMed · Cited by 75
Transcriptional control: Calling in histone deacetylase
Kiermaier, A. C., & Eilers, M. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00249-1 · Cited by 26
Chromatin Remodeling and Transcription
Hirose, S. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022220 · Cited by 12
Research works printed but not linked: 3
- Santoso JT, Tang D-C, Lane SB, Hung J, Reed DJ, Muller CY, Carbone DP, Lucci III JA, Miller DS, Mathis JM . 1995 Gynecol. Oncol. 59: 171–178 · doi:10.1006/gyno.1995.0002
- Somasundaram K, El-Deiry WS . 2000 Frontiers in Bioscience 5: 424–437 · doi:10.2741/a523
- Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL . 2000 Cancer Gene Ther. 7: 1469–1479 · doi:10.1038/sj.cgt.7700257
Cited by
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Metadata
- Authors
- Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., Nielsen, L. L., Pickett, C. B., & Liu, S.
- Venue
- Oncogene
- Published
- 2002-04-18
- Volume
- 21
- Issue
- 17
- Pages
- 2613-2622
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1992960292
- Cited by
- 530
- References
- 37
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.